Neel Radhakisan Lahoti
About Neel Radhakisan Lahoti
Neel Radhakisan Lahoti has 15 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 3 companies, including Synergen Bio Private Limited and Sarla Pharma Private Limited. Formerly with 2 companies. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Synergen Bio Private Limited
U74999PN2018PTC177201
|
Whole-Time Director | 14 Jun 2018 | 2018 | Active |
Nycg Buildcon Private Limited
U45202PN2022PTC216514
|
Director | 29 Nov 2022 | 2022 | Active |
Coldray Plasma Labs Private Limited
U32509PN2025PTC238649
|
Director | 25 Feb 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sarla Pharma Private Limited
U24239PN2011PTC139105
|
Director | 06 Apr 2011 | 2011 | Strike Off |
Novus Labs Private Limited
U24299PN2015PTC154616
|
Director | 07 Apr 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neel Radhakisan Lahoti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neel Radhakisan Lahoti
Neel Radhakisan Lahoti has 15 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 3 companies, including Synergen Bio Private Limited and Sarla Pharma Private Limited. Formerly with 2 companies. Engaged in General Business. Contributes to corporate operations.
Neel Radhakisan Lahoti is associated with 3 companies as Whole-Time Director and Director.
Neel Radhakisan Lahoti has expertise in General Business.
Neel Radhakisan Lahoti has 15 years in corporate governance.